Bigul

GKB OPHTHALMICS LTD. - 533212 - OUTCOME OF INDEPENDENT DIRECTORS'' MEETING HELD ON MARCH 17, 2022

A separate meeting of the Independent Directors of the Company for the year 2021-22, was held, pursuant to Regulation 25(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and section 149(8) of the Companies Act, 2013, read with Schedule IV (VII). Since all the Independent Directors were present, no leave of absence was granted. The Independent Directors in their Meeting held today: 1.Reviewed the performance of Non-Independent Directors and the Board as a whole. 2.Reviewed the performance of the Chairperson of the Company, taking into account the views of the Executive Director and Non-Executive Directors. 3.Assessed the quality, quantity and timeliness of the flow of information between the Company''s management and the Board. The Independent Directors'' Meeting started at 10:30 A.M. and ended at 11:15 A.M., on the same day. Kindly take note of the same.
17-03-2022
Bigul

GKB OPHTHALMICS LTD. - 533212 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find enclosed cuttings of the newspaper advertisements published in the The Times of India, Goa Edition dated March 12, 2022 and Pudhari (Marathi Edition) dated March 12, 2022 in connection with completion of dispatch of Postal Ballot Notice pursuant to Regulation 47 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. Please acknowledge receipt.
14-03-2022
Bigul

GKB OPHTHALMICS LTD. - 533212 - Intimation Of Separate Meeting Of Independent Directors To Be Held On Thursday, March 17, 2022.

Pursuant to Regulation 25(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a separate Board Meeting of the Independent Directors of the Company is scheduled to be held on Thursday, March 17, 2022 at 10.30 A.M at the Registered office of the Company situated at Plot No. 16-A , Tivim Industrial Estate, Mapusa, Goa , 403 526, to consider the following business: 1. To review the performance of Non-Independent Directors and the Board as a whole; 2. To review the performance of the Chairperson of the Company, taking into account the views of Executive Directors and Non-Executive Directors; 3. To assess the quality, quantity and timeliness of flow of information between the Company management and the Board that is necessary for the Board to effectively and reasonably perform their duties; 4. Any other business with the permission of chair.
12-03-2022
Bigul

GKB OPHTHALMICS LTD. - 533212 - Postal Ballot Notice Under Section 108 & 110 Of The Companies Act, 2013.

Pursuant to Regulation 30, of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Postal Ballot Notice dated March 07, 2022, for seeking the approval of members, by way of Ordinary Resolutions. The Notice of Postal Ballot, is available on the website of the Company at www.gkb.net, on the website of Stock Exchange i.e. BSE Limited at www.bseindia.com and on the website of CDSL at www.evotingindia.com The members of the Company, holding shares either in physical form or in dematerialized form, as on the cut-off date i.e. Friday, March 04, 2022, may cast their vote electronically. The Company has appointed CDSL for facilitating e-voting to enable the members to cast their votes electronically. The e-voting period begins on Saturday, March 12, 2022 at 9:00 A.M. and ends on Sunday, April 10, 2022 at 5:00 P.M. Kindly take the information on record.
11-03-2022
Bigul

GKB OPHTHALMICS LTD. - 533212 - Outcome Of Board Meeting Of GKB Ophthalmics Limited Held On March 07, 2022.

This is to inform that the meeting of the Board of Directors of the Company was held on March 07, 2022, in which the Board of Directors considered and approved: 1. Revised Policy on Related Party Transactions. 2. a) Related Party Transactions and b) Material Related Party Transactions, subject to the approval of shareholders. 3. Draft Postal Ballot Notice to seek consent of the Shareholders of the Company, for Material Related Party Transactions. This is for your kind information.
07-03-2022
Bigul

GKB OPHTHALMICS LTD. - 533212 - Dispatch Of KYC, Nomination Details And Forms To Physical Shareholders As Per SEBI Circular Dated 03/11/2021.

Pursuant to Regulation 30 and Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of the letter along with prescribed forms sent to the shareholders holding shares in physical mode in compliance with the SEBI Circulars dated 3rd November, 2021 and 14th December, 2021. The Company has informed the physical shareholders to furnish their valid PAN, KYC and nomination details to the Registrars and transfer Agent of the Company i.e, Link Intime India Private Limited. Forms are also made available on the Company's website at www.gkb.net This is for your information and records.
04-03-2022
Bigul

GKB OPHTHALMICS LTD. - 533212 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find attached copies of newspaper cuttings of the extract of Statement of Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2021, published in The Financial Express (Mumbai Edition) and on Pudhari (Marathi) dated February 14, 2022. Please acknowledge receipt.
15-02-2022
Bigul

GKB OPHTHALMICS LTD. - 533212 - Statement Of Deviation(S) Or Variation(S) Under Regulation 32 Of SEBI ( Listing Obligations And Disclosure Requirements ) Regulations , 2015

Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/162/2019, dated December 24, 2019, we would like to inform you that the Audit Committee in their meeting held on February 12, 2022, has reviewed the utilisation of funds which were raised by means of preferential allotment and noted that there was no utilization of funds, during the quarter ended December 31, 2021. Enclosed please find the Statement as per the format, giving details of the same. Kindly take the information on records.
12-02-2022
Bigul

GKB OPHTHALMICS LTD. - 533212 - Board Meeting Outcome for Outcome Of Board Meeting To Consider And Take On Record, The Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31, 2021

The meeting of the Board of Directors of the Company was held on February 12, 2022, which considered and took on record, the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2021. Pursuant to Regulation 33(3) (a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find the following: 1. Standalone financial results for the quarter and nine months ended December 31, 2021, together with the Limited Review Report. . 2. Consolidated financial results for the quarter and nine months ended December 31, 2021, together with the Limited Review Report. The above Unaudited standalone and consolidated financial results and the limited review reports are available on the Company's website www.gkb.net and the BSE website www.bseindia.com
12-02-2022
Bigul

GKB OPHTHALMICS LTD. - 533212 - Board Meeting Intimation for Considering And Taking On Record The Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2021.

GKB OPHTHALMICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2022 ,inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2021. Vide our letter dated December 31, 2021, notice was given with reference to the above meeting of the Board of Directors, that the Trading Window for dealing with equity shares of the Company, by designated persons, under the SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018, shall be closed from Saturday, January 01, 2022, till the completion of 48 hours after the declaration of the said financial results of the Company. The Trading Window shall now re-open on Tuesday, February 15, 2022. This communication has been sent to all the Directors and all the designated employees of the Company.
29-01-2022
Next Page
Close

Let's Open Free Demat Account